Training Program in Translational Research
Training Program in Translational Research
批准号:
9150858
负责人:
ANDREW P LIEBERMAN
金额:
$18.44万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-01 至 2021-06-30
中文摘要
摘要
翻译研究培训计划提供了一个跨学科的学习计划,
研究,准备研究生在基础之间的接口成功的职业生涯
生物医学和临床医学。该计划是专为博士预科博士。
旨在解决广泛公认的训练有素的科学家短缺问题
他们可以成功地与医疗专业人员合作,
科学和临床实践。该计划是集中在密歇根大学学院的
医学,参与的教职员工隶属于十二个部门(7个临床和
5基础科学)。额外的教师导师有他们的主要任命在学校的
药学和牙科学院。这些教师被选中是因为他们的
致力于研究生教育和翻译研究的专业知识。基于长期-
这些研究导师的长期利益,科学项目将集中在以下领域:
在癌症生物学、发育、表观遗传学、衰老、免疫学、神经科学和
实验疗法和生物标志物。这种广泛的研究活动提供了一个
广泛的令人兴奋的机会,让学生从事翻译研究项目。的
教育经验将得到加强,并通过整合双导师与
在研究项目的基础和临床方面具有相应的专业知识。课程
包括转化研究的创新课程和学生参与临床
轮换、跨学科会议、肿瘤委员会和大查房。这些活动将
辅以T32系列研讨会和期刊俱乐部以及年度务虚会。的
该计划将由共同董事谁是经验丰富,并热衷于,
研究生教育和转化研究。该计划将受益于建议
指导委员会和外部咨询委员会的监督,
共同主任在运行和评估该计划。该计划的毕业生将拥有
技能和知识,从事独立的职业生涯,具有翻译
多学科研究。总之,这个培训项目的优势是直接联系
基础科学和临床科学之间,学院和成功的导师,
经验丰富的项目领导,以及丰富的学术研究和临床环境,
密歇根大学
英文摘要
Abstract
The Training Program in Translational Research offers an interdisciplinary program of study and
research that prepares graduate students for successful careers at the interface between basic
biomedical science and clinical medicine. This program is designed for predoctoral Ph.D.
students and aims to address the widely-recognized shortage of rigorously trained scientists
who can successfully work together with medical professionals to bridge the gap between basic
science and clinical practice. The program is centered in the University of Michigan School of
Medicine, with participating faculty members affiliated with a twelve departments (7 clinical and
5 basic science). Additional faculty mentors have their primary appointments in the School of
Pharmacy and School of Dentistry. These faculty members were selected because of their
commitment to graduate education and expertise in translational research. Based on the long-
standing interests of these research preceptors, scientific projects will be focused on areas of
excellence in cancer biology, development, epigenetics, aging, immunology, neuroscience and
experimental therapeutics & biomarkers. This broad spectrum of research activities provides a
wide-range of exciting opportunities for students to work on translational research projects. The
educational experience will be enhanced and supported by integration of dual-mentors with
corresponding expertise in the basic and clinical aspects of the research project. The curriculum
includes innovative coursework in translational research and student participation in clinical
rotations, interdisciplinary conferences, tumor boards, and grand rounds. These activities will be
complemented by a T32-based seminar series and journal club and an annual retreat. The
program will be administered by co-directors who are experienced in, and passionate about,
graduate student education and translational research. The program will benefit from the advice
and oversight of a steering committee and an external advisory board, both of which will assist
the co-directors in running and evaluating the program. Graduates from this program will have
the skills and knowledge to undertake an independent career that features translational
multidisciplinary research. In summary, the strengths of this training program are the direct link
between the basic and clinical sciences, the collegial and successful preceptors, the
experienced program leadership, and the rich academic research and clinical environment at
the University of Michigan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Translational Research
-
批准号:10415974
-
项目类别:
-
资助金额:$31.22万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration
-
批准号:10907065
-
项目类别:
-
资助金额:$7.75万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Core D: Neuropathology Core
-
批准号:10663300
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Mechanisms of neuromuscular degeneration in SBMA
-
批准号:10471367
-
项目类别:
-
资助金额:$53.82万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Therapeutic targets for Niemann-Pick type C neurodegeneration
-
批准号:10271742
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Training Program in Translational Research
-
批准号:10618868
-
项目类别:
-
资助金额:$31.83万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Mechanisms of neuromuscular degeneration in SBMA
-
批准号:10290437
-
项目类别:
-
资助金额:$55.1万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Core D: Neuropathology Core
-
批准号:10473821
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Core D: Neuropathology Core
-
批准号:10261112
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration
-
批准号:10468243
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Training Program in Translational Research
-
批准号:10205196
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Mechanisms of neuromuscular degeneration in SBMA
-
批准号:10630945
-
项目类别:
-
资助金额:$59.9万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Therapeutic Targets for Niemann-Pick Type C Neurodegeneration
-
批准号:10664999
-
项目类别:
-
资助金额:$56.31万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Therapeutic targets for Niemann-Pick type C neurodegeneration
-
批准号:10620477
-
项目类别:
-
资助金额:$7.87万
-
财政年份:2021
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
A mouse model Niemann-Pick type C disease to test proteostasis therapies
-
批准号:10038058
-
项目类别:
-
资助金额:$14.85万
-
财政年份:2020
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Small molecule stabilizers of Hsp70 for treatment of spinal and bulbar muscular atrophy
-
批准号:9812011
-
项目类别:
-
资助金额:$38.91万
-
财政年份:2017
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Antisense oligonucleotides to treat spinal and bulbar muscular atrophy
-
批准号:8931087
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Antisense oligonucleotides to treat spinal and bulbar muscular atrophy
-
批准号:8798144
-
项目类别:
-
资助金额:$38.85万
-
财政年份:2014
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Androgen Receptor SUMOylation in SBMA
-
批准号:8669827
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2013
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
Androgen Receptor SUMOylation in SBMA
-
批准号:8563749
-
项目类别:
-
资助金额:$7.78万
-
财政年份:2013
-
负责人:ANDREW P LIEBERMAN
-
依托单位:
海外基金